Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824856) titled 'Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma' on Sept. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Sun Yat-sen University
Condition:
Nasopharyngeal Carcinoma
Neoplasm Metastasis
Lung Metastases
Liver Metastases
Oligometastatic Disease
Ablation Techniques
Intervention:
Procedure: CT-guided percutaneous local ablation
Drug: Gemcitabine
Drug: Cisplatin
Recruitment Status: Not recruiting
Phase: Phase 2 ...